These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 9344867)

  • 1. Asp278 of human beta-adrenergic receptor kinase 1 is essential for phosphorylation activity.
    Iino M; Furugohri T; Fukuzawa A; Shibano T
    Biochem Biophys Res Commun; 1997 Oct; 239(2):548-51. PubMed ID: 9344867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The full-length, cytoplasmic C-terminus of the beta 2-adrenergic receptor expressed in E. coli acts as a substrate for phosphorylation by protein kinase A, insulin receptor tyrosine kinase, GRK2, but not protein kinase C and suppresses desensitization when expressed in vivo.
    Doronin S; Lin F; Wang HY; Malbon CC
    Protein Expr Purif; 2000 Dec; 20(3):451-61. PubMed ID: 11087685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the functional role of beta-adrenergic receptor kinase 1 amino-terminal.
    Sallese M; Lombardi MS; Haske TN; LeVine H; De Blasi A
    J Recept Signal Transduct Res; 1995; 15(1-4):81-90. PubMed ID: 8903933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate recognition mechanism of human beta-adrenergic receptor kinase 1 based on a three-dimensional model structure.
    Iino M; Shibano T
    Drug Des Discov; 1996 Oct; 14(2):145-55. PubMed ID: 9010620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone inhibits protein kinase A (PKA) in Xenopus oocytes: demonstration of endogenous PKA activities using an expressed substrate.
    Wang J; Liu XJ
    J Cell Sci; 2004 Oct; 117(Pt 21):5107-16. PubMed ID: 15456849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase.
    Klingbeil CK; Gill GN
    Arch Biochem Biophys; 1999 Mar; 363(1):27-32. PubMed ID: 10049496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the sites phosphorylated by cyclic AMP-dependent protein kinase on the beta 2 subunit of L-type voltage-dependent calcium channels.
    Gerhardstein BL; Puri TS; Chien AJ; Hosey MM
    Biochemistry; 1999 Aug; 38(32):10361-70. PubMed ID: 10441130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis of important amino acid reveals unconventional homologous internalization of beta(1)-adrenergic receptor.
    Hossain M; Rashid M; Bhuiyan MA; Nakamura T; Ozaki M; Nagatomo T
    Life Sci; 2009 Aug; 85(7-8):339-44. PubMed ID: 19580817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation.
    Scheer A; Costa T; Fanelli F; De Benedetti PG; Mhaouty-Kodja S; Abuin L; Nenniger-Tosato M; Cotecchia S
    Mol Pharmacol; 2000 Feb; 57(2):219-31. PubMed ID: 10648631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma.
    Lodowski DT; Pitcher JA; Capel WD; Lefkowitz RJ; Tesmer JJ
    Science; 2003 May; 300(5623):1256-62. PubMed ID: 12764189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.
    Tran TM; Friedman J; Qunaibi E; Baameur F; Moore RH; Clark RB
    Mol Pharmacol; 2004 Jan; 65(1):196-206. PubMed ID: 14722251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
    Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
    J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of wild-type and catalytically inactive forms of GRK2 and GRK6 fails to alter the agonist-induced phosphorylation of the C5a receptor (CD88): evidence that GRK6 is autophosphorylated in COS-7 cells.
    Milcent MD; Christophe T; Rabiet MJ; Tardif M; Boulay F
    Biochem Biophys Res Commun; 1999 May; 259(1):224-9. PubMed ID: 10334944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of CYP2E1 activity by cAMP-dependent protein kinase upon Ser129 replacement.
    Oesch-Bartlomowicz B; Padma PR; Becker R; Richter B; Hengstler JG; Freeman JE; Wolf CR; Oesch F
    Exp Cell Res; 1998 Jul; 242(1):294-302. PubMed ID: 9665827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.
    Daaka Y; Luttrell LM; Lefkowitz RJ
    Nature; 1997 Nov; 390(6655):88-91. PubMed ID: 9363896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase.
    Saxena M; Williams S; Taskén K; Mustelin T
    Nat Cell Biol; 1999 Sep; 1(5):305-11. PubMed ID: 10559944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of intramolecular interactions in the regulation of G protein-coupled receptor kinase 2.
    Sarnago S; Roca R; de Blasi A; Valencia A; Mayor F; Murga C
    Mol Pharmacol; 2003 Sep; 64(3):629-39. PubMed ID: 12920199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation.
    Kim C; Cheng CY; Saldanha SA; Taylor SS
    Cell; 2007 Sep; 130(6):1032-43. PubMed ID: 17889648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
    Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
    Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
    Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
    J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.